Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2013
11/12/2013US8580248 Culture and use of cells that secrete liver secretory factors
11/12/2013US8580246 Surfactant-free stable pharmaceutical composition comprising granulocyte-colony stimulating factor
11/12/2013US8580140 Cyclopropene complex compositions
11/12/2013US8579885 MEMS electrochemical bellows actuator
11/12/2013US8579883 Body-insertable apparatus and medical agent discharge method
11/12/2013CA2782511C Circulation of components during homogenization of emulsions
11/12/2013CA2771571C Highly concentrated pharmaceutical formulations
11/12/2013CA2733509C Antimicrobial silver solutions
11/12/2013CA2698495C Transdermal drug delivery systems comprising a coated release liner
11/12/2013CA2684592C Liquid formulations of salts of 4-[2-(4-methylphenylsulfanyl)phenyl]piperidine
11/12/2013CA2673334C Oral extended-release composition
11/12/2013CA2664637C Dried reconstituted vesicle formation for pharmaceutical application
11/12/2013CA2648658C Colonic drug delivery formulation
11/12/2013CA2606851C Composition and method for treating nosebleeds
11/12/2013CA2599649C Drug formulations having controlled bioavailability
11/12/2013CA2591056C Stable solid dispersion of a derivative of vinca alkaloid and process for manufacturing it
11/12/2013CA2586395C Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof
11/12/2013CA2581831C Pharmaceutical compositions comprising levetiracetam and process for their preparation
11/12/2013CA2557999C Methods and compositions for treatment of ion imbalances
11/12/2013CA2548281C Method of preparation of mixed phase co-crystals with active agents
11/12/2013CA2547531C Buoyant polymer particles for delivery of therapeutic agents to the central nervous system
11/12/2013CA2535398C Antibiotic product, use and formulation thereof
11/12/2013CA2522098C Absorption enhancers such as bht, bha or propylgallate
11/12/2013CA2514325C A composition material for transmucosal delivery
11/12/2013CA2490516C Honey-based skin care preparation
11/12/2013CA2448379C Calorically dense liquid oral supplement
11/12/2013CA2448022C Compositions for protein delivery via the pulmonary route
11/10/2013CA2776618A1 Compositions and methods for promoting liposomal and cellular adhesion
11/08/2013CA2783146A1 Compositions and methods for encapsulating vaccines for the oral vaccination and boostering of fish and other animals
11/07/2013WO2013166498A1 Lipid-based drug carriers for rapid penetration through mucus linings
11/07/2013WO2013166487A1 Highly penetrative nanocarriers for treatment of cns disease
11/07/2013WO2013166436A1 Pharmaceutical nanoparticles showing improved mucosal transport
11/07/2013WO2013166408A1 Pharmaceutical nanoparticles showing improved mucosal transport
11/07/2013WO2013166399A1 Ophthalmic compositions with improved dessication protection and retention
11/07/2013WO2013166385A1 Pharmaceutical nanoparticles showing improved mucosal transport
11/07/2013WO2013166218A1 Deactivation of urushiol and method of treatment and prevention of contact dermatitis
11/07/2013WO2013166206A1 A prenylated anthracenone polyketide as an immunosuppressant
11/07/2013WO2013166144A1 Method of manufacturing solid dosage form
11/07/2013WO2013166136A1 Tablet comprising a first and second region
11/07/2013WO2013166131A2 Orally disintegrating tablet
11/07/2013WO2013166117A1 Oral tablet formulation consisting of fixed combination of rosuvastatin and ezetimibe for treatment of hyperlipidemia and cardiovascular diseases
11/07/2013WO2013166114A1 Oral tablet formulation consisting of fixed combination of atorvastatin and ezetimibe
11/07/2013WO2013165902A1 Bromocriptine formulations
11/07/2013WO2013165482A1 Emulsified mq resin: compositions and methods
11/07/2013WO2013165468A1 Pharmaceutical compositions for direct systemic introduction
11/07/2013WO2013165330A1 Stable effervescent formulations
11/07/2013WO2013165327A1 Pharmaceutical formulations comprising thiocolchicoside
11/07/2013WO2013165264A1 Anthelmintic compositions
11/07/2013WO2013165131A1 Natural lubricant for direct compression and method for preparing natural tablet using the same
11/07/2013WO2013165021A1 Oral formulation
11/07/2013WO2013164857A1 Desvenlafaxine succinate solid dispersion
11/07/2013WO2013164837A1 Pharmaceutical formulations of tnf-alpha antibodies
11/07/2013WO2013164758A1 Fluorescent, spherical sophorolipid mesostructures for imaging and therapeutic applications
11/07/2013WO2013164711A1 Anti-adherent formulation including a cationic or nonionic acrylate co-polymer
11/07/2013WO2013164684A1 Veterinary kit and method for compounding medicated treats
11/07/2013WO2013164671A1 Drug delivery system and methods of treating open angle glaucoma and ocular hypertension
11/07/2013WO2013164636A1 Avermectin pour-on formulation with reduced withdrawal time
11/07/2013WO2013164620A1 New alfentanil composition for the treatment of acute pain
11/07/2013WO2013164617A1 New sufentanil composition for the treatment of acute pain
11/07/2013WO2013164559A1 Antiretroviral composition
11/07/2013WO2013164485A1 Ready to drink beverages and methods of making thereof
11/07/2013WO2013164473A1 Pharmaceutical composition comprising abiraterone acetate
11/07/2013WO2013164382A1 Aqueous, sterile vitamin formulation
11/07/2013WO2013164380A1 Polyinosinic-polycytidylic acid (poly (i:c)) formulations for the treatment of upper respiratory tract infections
11/07/2013WO2013164316A1 A delayed release drug formulation
11/07/2013WO2013164315A1 A delayed release drug formulation
11/07/2013WO2013164257A1 New formulation
11/07/2013WO2013164122A1 Aqueous dispersions of controlled release polymers and shells and capsules thereof
11/07/2013WO2013164121A1 Aqueous dispersions of hydroxypropyl methylcellulose acetate succinate (hpmcas)
11/07/2013WO2013163738A1 Complex containing carboxyl substituted starch and lipid for delayed delivery of active ingredients
11/07/2013WO2013124832A3 Stabilized controlled-release pharmaceutical composition comprising gliclazide
11/07/2013WO2013123492A3 Glucose-responsive microgels for closed loop insulin delivery
11/07/2013WO2013119607A3 Modified release formulations of (+)-2-[1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-4-acetyl aminoisoindoline-1,3-dione
11/07/2013WO2013114400A3 Compressed pharmaceutical compositions of atypical antipsychotics
11/07/2013WO2013084208A3 Liposomes and corresponding production method
11/07/2013WO2013009701A9 Metal bisphosphonate nanoparticles for anti-cancer therapy and imaging and for treating bone disorders
11/07/2013WO2012047582A3 Compositions useful for target, detection, imaging and treatment, and methods of production and use thereof
11/07/2013US20130297040 Implant having a core and a tube encasing the core
11/07/2013US20130296833 Biodegradable osmotic pump implant for drug delivery
11/07/2013US20130296829 Non-sedating antihistamine injection formulations and methods of use thereof
11/07/2013US20130296445 Natural Lubricant for Direct Compression and Method for Preparing Natural Tablet Using the Same
11/07/2013US20130296396 Compositions for delivery of therapeutics into the eyes and methods for making and using same
11/07/2013US20130296385 Fast Dissolving Tablet
11/07/2013US20130296368 Sublingual fentanyl spray
11/07/2013US20130296337 Flashmelt oral dosage formulation
11/07/2013US20130296325 HIGH DRUG LOAD TABLET FORMULATION OF [(1R), 2S]-2-AMINOPROPIONIC ACID 2-[4-(4-FLUORO-2-METHYL-1H-INDOL-5-YLOXY)-5-METHYLPYRROLO[2,1-f][1,2,4]TRIAZIN-6-YLOXY]-1-METHYLETHYL ESTER
11/07/2013US20130296287 Focal photodynamic therapy methods
11/07/2013US20130296284 Microemulsion & sub-micron emulsion process & compositions
11/07/2013US20130296277 Pharmaceutical Compositions for the Treatment of Parasitic Diseases, Cancer, or Skin Diseases by Topical Administration
11/07/2013US20130296267 Agent for intra-articular injection
11/07/2013US20130296266 Pharmaceutical Composition of Complex Carbohydrates and Essential Oils and Methods of Using the Same
11/07/2013US20130296259 Pharmaceutical compositions containing botulinum neurotoxin
11/07/2013US20130295189 Method for manufacturing acid pellets
11/07/2013US20130295188 Bulk enteric capsule shells
11/07/2013US20130295187 NOVEL FORMULATIONS OF FACTOR VIIa INHIBITORS AND UTILITY
11/07/2013US20130295186 Method for coating particles with calcium phosphate and particles, microparticles and nanoparticles formed thereof
11/07/2013US20130295185 Compounds and methods for inducing apoptosis in cancer cells using a bh3 alpha-helical mimetic
11/07/2013US20130295184 Medical devices with galvanic particulates
11/07/2013US20130295183 Stable Formulations for Lyophilizing Therapeutic Particles
11/07/2013US20130295181 Compositions based on propolis nanocapsules which can be used as carriers for substances of interest, methods for producing same and use thereof
1 ... 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 ... 2991